| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 51 | 2024 | 1667 | 8.810 |
Why?
|
| Regeneration | 34 | 2022 | 1505 | 5.990 |
Why?
|
| Thioredoxins | 22 | 2023 | 202 | 5.250 |
Why?
|
| Heart | 33 | 2022 | 4403 | 4.400 |
Why?
|
| Myocardium | 45 | 2022 | 4725 | 4.100 |
Why?
|
| Growth Differentiation Factors | 12 | 2023 | 100 | 3.640 |
Why?
|
| Regenerative Medicine | 9 | 2022 | 306 | 2.690 |
Why?
|
| Myostatin | 6 | 2023 | 129 | 2.620 |
Why?
|
| Bone Morphogenetic Proteins | 11 | 2023 | 841 | 2.570 |
Why?
|
| Arrestins | 6 | 2023 | 73 | 2.380 |
Why?
|
| Carrier Proteins | 22 | 2016 | 4937 | 2.220 |
Why?
|
| Stem Cell Transplantation | 9 | 2022 | 1600 | 1.640 |
Why?
|
| Muscle, Smooth, Vascular | 16 | 2011 | 1492 | 1.610 |
Why?
|
| Interleukins | 10 | 2019 | 783 | 1.590 |
Why?
|
| Induced Pluripotent Stem Cells | 7 | 2024 | 1851 | 1.580 |
Why?
|
| Pluripotent Stem Cells | 5 | 2021 | 796 | 1.450 |
Why?
|
| Cardiomegaly | 7 | 2015 | 590 | 1.430 |
Why?
|
| Myocardial Reperfusion Injury | 6 | 2013 | 481 | 1.430 |
Why?
|
| Arteriosclerosis | 13 | 2005 | 1056 | 1.350 |
Why?
|
| Myocardial Infarction | 39 | 2018 | 11458 | 1.310 |
Why?
|
| Animals | 171 | 2024 | 168202 | 1.260 |
Why?
|
| Receptors, Cell Surface | 13 | 2013 | 2802 | 1.190 |
Why?
|
| Stem Cells | 17 | 2021 | 3514 | 1.140 |
Why?
|
| Mechanotransduction, Cellular | 9 | 2010 | 528 | 1.120 |
Why?
|
| Gene Deletion | 9 | 2019 | 2659 | 1.100 |
Why?
|
| Neovascularization, Physiologic | 10 | 2011 | 1349 | 1.060 |
Why?
|
| Signal Transduction | 36 | 2024 | 23415 | 1.060 |
Why?
|
| Mice | 99 | 2024 | 81368 | 1.060 |
Why?
|
| Aging | 15 | 2022 | 8700 | 1.030 |
Why?
|
| Stress, Mechanical | 27 | 2012 | 1674 | 1.020 |
Why?
|
| Cell Differentiation | 21 | 2024 | 11512 | 0.970 |
Why?
|
| Receptors, Interleukin-1 | 4 | 2009 | 262 | 0.950 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2017 | 242 | 0.890 |
Why?
|
| Lamin Type A | 6 | 2009 | 186 | 0.870 |
Why?
|
| Heart Diseases | 9 | 2017 | 2778 | 0.870 |
Why?
|
| Glucose | 8 | 2023 | 4345 | 0.850 |
Why?
|
| Gene Expression Regulation | 23 | 2020 | 11874 | 0.840 |
Why?
|
| Mitochondria, Heart | 3 | 2013 | 229 | 0.820 |
Why?
|
| Ventricular Remodeling | 12 | 2019 | 1265 | 0.810 |
Why?
|
| Cell Nucleus | 8 | 2012 | 2894 | 0.790 |
Why?
|
| Fibrosis | 8 | 2022 | 2047 | 0.780 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2024 | 2916 | 0.770 |
Why?
|
| Cells, Cultured | 44 | 2024 | 18937 | 0.760 |
Why?
|
| Paracrine Communication | 3 | 2012 | 277 | 0.750 |
Why?
|
| Chemokine CXCL12 | 4 | 2011 | 454 | 0.740 |
Why?
|
| Glucagon | 1 | 2023 | 531 | 0.740 |
Why?
|
| Cell Proliferation | 23 | 2019 | 10429 | 0.740 |
Why?
|
| Physical Conditioning, Animal | 2 | 2022 | 366 | 0.740 |
Why?
|
| Insulin | 6 | 2023 | 6593 | 0.730 |
Why?
|
| Cardiotonic Agents | 4 | 2013 | 539 | 0.730 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 2 | 2017 | 23 | 0.720 |
Why?
|
| Animals, Newborn | 12 | 2018 | 2669 | 0.710 |
Why?
|
| Mice, Knockout | 27 | 2020 | 14388 | 0.700 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2017 | 1932 | 0.690 |
Why?
|
| Tissue Engineering | 6 | 2016 | 1865 | 0.690 |
Why?
|
| Endothelial Cells | 10 | 2023 | 3550 | 0.680 |
Why?
|
| Rats | 37 | 2023 | 23716 | 0.680 |
Why?
|
| Mice, Inbred C57BL | 31 | 2023 | 22117 | 0.670 |
Why?
|
| Sirtuins | 2 | 2020 | 319 | 0.670 |
Why?
|
| Tunica Intima | 3 | 2010 | 458 | 0.670 |
Why?
|
| Bone Development | 1 | 2023 | 470 | 0.670 |
Why?
|
| Viscum album | 1 | 2019 | 4 | 0.660 |
Why?
|
| Microfluidic Analytical Techniques | 5 | 2015 | 799 | 0.660 |
Why?
|
| Plant Lectins | 1 | 2019 | 103 | 0.650 |
Why?
|
| Myocardial Contraction | 6 | 2019 | 1515 | 0.640 |
Why?
|
| Myoblasts, Cardiac | 3 | 2013 | 21 | 0.640 |
Why?
|
| Protein Engineering | 4 | 2013 | 548 | 0.640 |
Why?
|
| Receptors, Interleukin | 6 | 2015 | 243 | 0.640 |
Why?
|
| Heart Failure | 16 | 2020 | 11670 | 0.630 |
Why?
|
| Hypertrophy, Left Ventricular | 8 | 2013 | 851 | 0.630 |
Why?
|
| Naphthyridines | 1 | 2019 | 143 | 0.630 |
Why?
|
| Mammals | 4 | 2017 | 1131 | 0.620 |
Why?
|
| Liver | 3 | 2023 | 7512 | 0.620 |
Why?
|
| Cell Transplantation | 3 | 2012 | 472 | 0.600 |
Why?
|
| Platelet-Derived Growth Factor | 6 | 2010 | 618 | 0.590 |
Why?
|
| Actomyosin | 1 | 2018 | 109 | 0.590 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2018 | 87 | 0.590 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2021 | 8165 | 0.580 |
Why?
|
| Dietary Sucrose | 1 | 2019 | 243 | 0.580 |
Why?
|
| Identity Crisis | 1 | 2016 | 12 | 0.570 |
Why?
|
| Adsorption | 2 | 2016 | 197 | 0.570 |
Why?
|
| Oxidative Stress | 11 | 2016 | 3115 | 0.560 |
Why?
|
| Energy Metabolism | 6 | 2020 | 2878 | 0.560 |
Why?
|
| Extracellular Space | 2 | 2018 | 562 | 0.550 |
Why?
|
| Endothelium, Vascular | 10 | 2019 | 4433 | 0.550 |
Why?
|
| Cell Movement | 12 | 2019 | 5201 | 0.550 |
Why?
|
| Insulin Resistance | 3 | 2020 | 3954 | 0.550 |
Why?
|
| Neuregulin-1 | 3 | 2015 | 135 | 0.550 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 597 | 0.550 |
Why?
|
| Integrases | 1 | 2019 | 518 | 0.540 |
Why?
|
| Peptides | 8 | 2015 | 4354 | 0.540 |
Why?
|
| Adult Stem Cells | 1 | 2018 | 221 | 0.540 |
Why?
|
| Collagenases | 5 | 2009 | 222 | 0.540 |
Why?
|
| Adipose Tissue, White | 2 | 2017 | 359 | 0.530 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2023 | 2872 | 0.530 |
Why?
|
| Myocardial Ischemia | 5 | 2017 | 2110 | 0.530 |
Why?
|
| GATA4 Transcription Factor | 1 | 2016 | 124 | 0.520 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 836 | 0.520 |
Why?
|
| Cardiomyopathies | 4 | 2020 | 1948 | 0.520 |
Why?
|
| Fibroblasts | 12 | 2012 | 4140 | 0.510 |
Why?
|
| Humans | 169 | 2024 | 760740 | 0.500 |
Why?
|
| Apolipoproteins E | 4 | 2018 | 1443 | 0.500 |
Why?
|
| Membrane Proteins | 11 | 2007 | 7847 | 0.500 |
Why?
|
| Biocompatible Materials | 3 | 2011 | 1683 | 0.490 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2019 | 620 | 0.490 |
Why?
|
| Parabiosis | 3 | 2014 | 64 | 0.490 |
Why?
|
| Aortic Valve Insufficiency | 8 | 2008 | 576 | 0.490 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 7583 | 0.470 |
Why?
|
| Fructose | 1 | 2016 | 288 | 0.470 |
Why?
|
| Disease Models, Animal | 20 | 2024 | 18220 | 0.470 |
Why?
|
| Echocardiography, Doppler | 11 | 2020 | 893 | 0.460 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2019 | 831 | 0.450 |
Why?
|
| Chemical Engineering | 1 | 2013 | 15 | 0.440 |
Why?
|
| Elasticity | 7 | 2010 | 655 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 988 | 0.440 |
Why?
|
| Insulin-Secreting Cells | 2 | 2018 | 898 | 0.440 |
Why?
|
| Neural Crest | 1 | 2016 | 278 | 0.440 |
Why?
|
| Extracellular Matrix | 7 | 2010 | 1718 | 0.430 |
Why?
|
| Arrestin | 2 | 2011 | 30 | 0.430 |
Why?
|
| Dietary Fats | 2 | 2019 | 1995 | 0.430 |
Why?
|
| Heart Ventricles | 12 | 2019 | 3796 | 0.430 |
Why?
|
| Matrix Metalloproteinases | 5 | 2014 | 391 | 0.420 |
Why?
|
| Aorta | 9 | 2005 | 2041 | 0.420 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2011 | 1723 | 0.410 |
Why?
|
| Proteins | 5 | 2021 | 6030 | 0.410 |
Why?
|
| Collagen | 8 | 2009 | 2634 | 0.410 |
Why?
|
| Reactive Oxygen Species | 9 | 2015 | 2137 | 0.410 |
Why?
|
| Stress, Physiological | 5 | 2012 | 1403 | 0.400 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2014 | 208 | 0.400 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3400 | 0.400 |
Why?
|
| Immediate-Early Proteins | 4 | 2003 | 444 | 0.390 |
Why?
|
| Muscle, Skeletal | 4 | 2023 | 4947 | 0.380 |
Why?
|
| Matrix Metalloproteinase 2 | 4 | 2011 | 459 | 0.380 |
Why?
|
| Troponin T | 2 | 2018 | 780 | 0.370 |
Why?
|
| RNA, Messenger | 23 | 2012 | 12759 | 0.370 |
Why?
|
| Stroke Volume | 8 | 2020 | 5486 | 0.360 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 2057 | 0.360 |
Why?
|
| Echocardiography | 16 | 2018 | 4987 | 0.360 |
Why?
|
| Heart Injuries | 2 | 2014 | 203 | 0.350 |
Why?
|
| Drug Delivery Systems | 6 | 2017 | 2222 | 0.350 |
Why?
|
| Lamin Type B | 2 | 2007 | 26 | 0.340 |
Why?
|
| Adipogenesis | 2 | 2017 | 366 | 0.340 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2005 | 1517 | 0.340 |
Why?
|
| Peptide Library | 1 | 2011 | 347 | 0.330 |
Why?
|
| Models, Cardiovascular | 6 | 2011 | 981 | 0.330 |
Why?
|
| Adrenomedullin | 1 | 2009 | 85 | 0.330 |
Why?
|
| Cell Survival | 11 | 2014 | 5780 | 0.330 |
Why?
|
| Apoptosis | 14 | 2019 | 9476 | 0.330 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 1880 | 0.330 |
Why?
|
| Recombinant Proteins | 9 | 2020 | 6520 | 0.330 |
Why?
|
| Body Weight | 1 | 2020 | 4615 | 0.320 |
Why?
|
| Cardiology | 2 | 2017 | 1656 | 0.310 |
Why?
|
| Embryo, Mammalian | 3 | 2021 | 1670 | 0.310 |
Why?
|
| DNA | 5 | 2023 | 7196 | 0.310 |
Why?
|
| Epidermal Growth Factor | 2 | 2015 | 699 | 0.300 |
Why?
|
| Integrins | 4 | 2004 | 834 | 0.300 |
Why?
|
| Cell Cycle | 5 | 2016 | 2929 | 0.300 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 3794 | 0.300 |
Why?
|
| Inflammation | 10 | 2023 | 10759 | 0.300 |
Why?
|
| Cytoskeleton | 4 | 2007 | 1170 | 0.300 |
Why?
|
| Receptors, CXCR4 | 2 | 2011 | 727 | 0.300 |
Why?
|
| Micromanipulation | 2 | 2004 | 53 | 0.290 |
Why?
|
| Male | 81 | 2024 | 360402 | 0.290 |
Why?
|
| Glutathione | 2 | 2007 | 582 | 0.290 |
Why?
|
| Interleukin-1 | 8 | 2003 | 1248 | 0.290 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2013 | 499 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-sis | 4 | 2016 | 255 | 0.280 |
Why?
|
| Matrix Metalloproteinase 9 | 5 | 2005 | 631 | 0.280 |
Why?
|
| Peptide Fragments | 2 | 2011 | 5109 | 0.280 |
Why?
|
| Thermogenesis | 1 | 2011 | 474 | 0.280 |
Why?
|
| Monocytes | 4 | 2002 | 2565 | 0.280 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2006 | 20 | 0.280 |
Why?
|
| Morphogenesis | 2 | 2008 | 741 | 0.280 |
Why?
|
| Hepatocytes | 2 | 2019 | 1231 | 0.280 |
Why?
|
| Oxidation-Reduction | 7 | 2023 | 2231 | 0.280 |
Why?
|
| Nitro Compounds | 1 | 2006 | 74 | 0.270 |
Why?
|
| Capillaries | 2 | 2011 | 756 | 0.270 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2292 | 0.270 |
Why?
|
| Cell Line | 12 | 2019 | 15577 | 0.270 |
Why?
|
| Doxorubicin | 1 | 2013 | 2224 | 0.270 |
Why?
|
| Zebrafish | 6 | 2021 | 3005 | 0.270 |
Why?
|
| Ventricular Function | 3 | 2009 | 406 | 0.270 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 629 | 0.260 |
Why?
|
| NF-kappa B | 7 | 2013 | 2481 | 0.260 |
Why?
|
| Myoblasts, Skeletal | 3 | 2014 | 75 | 0.260 |
Why?
|
| Hypertension | 5 | 2015 | 8532 | 0.260 |
Why?
|
| Thymopoietins | 1 | 2005 | 10 | 0.260 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 384 | 0.260 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 416 | 0.260 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2005 | 186 | 0.260 |
Why?
|
| Metalloendopeptidases | 2 | 1999 | 393 | 0.260 |
Why?
|
| Nanomedicine | 2 | 2019 | 289 | 0.260 |
Why?
|
| Multipotent Stem Cells | 2 | 2018 | 200 | 0.250 |
Why?
|
| Cytokinesis | 2 | 2018 | 169 | 0.250 |
Why?
|
| Veins | 1 | 2010 | 767 | 0.250 |
Why?
|
| Adipose Tissue, Brown | 1 | 2011 | 762 | 0.250 |
Why?
|
| Cardiovascular Diseases | 7 | 2022 | 15498 | 0.250 |
Why?
|
| Nanotubes, Peptide | 1 | 2005 | 1 | 0.250 |
Why?
|
| Blotting, Northern | 7 | 2005 | 1545 | 0.250 |
Why?
|
| Aorta, Abdominal | 4 | 2009 | 625 | 0.240 |
Why?
|
| Mitochondria | 4 | 2021 | 3619 | 0.240 |
Why?
|
| Heart Valve Diseases | 4 | 2008 | 1028 | 0.240 |
Why?
|
| Myosin Heavy Chains | 3 | 2019 | 404 | 0.240 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 191 | 0.240 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2013 | 1642 | 0.240 |
Why?
|
| Amino Acid Sequence | 10 | 2017 | 13442 | 0.240 |
Why?
|
| Calcineurin | 2 | 2022 | 229 | 0.240 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 495 | 0.230 |
Why?
|
| Macrophages | 6 | 2005 | 5758 | 0.230 |
Why?
|
| Connexin 43 | 1 | 2005 | 200 | 0.230 |
Why?
|
| Ascorbic Acid | 2 | 2009 | 655 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2010 | 1650 | 0.230 |
Why?
|
| Muscle Development | 2 | 2017 | 259 | 0.230 |
Why?
|
| Gene Targeting | 1 | 2007 | 837 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2016 | 2747 | 0.230 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 1997 | 592 | 0.230 |
Why?
|
| Disulfides | 1 | 2006 | 464 | 0.230 |
Why?
|
| Thymidine | 2 | 2022 | 297 | 0.230 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 840 | 0.230 |
Why?
|
| Receptors, Transferrin | 2 | 2004 | 291 | 0.230 |
Why?
|
| Magnetics | 4 | 2004 | 597 | 0.220 |
Why?
|
| Fetal Heart | 1 | 2005 | 281 | 0.220 |
Why?
|
| Interleukin-4 | 4 | 2019 | 1146 | 0.220 |
Why?
|
| Chemokines, CC | 2 | 2004 | 283 | 0.220 |
Why?
|
| Adiposity | 2 | 2012 | 1879 | 0.220 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2004 | 325 | 0.220 |
Why?
|
| Heparan Sulfate Proteoglycans | 3 | 2018 | 112 | 0.220 |
Why?
|
| DNA Adducts | 1 | 2023 | 94 | 0.220 |
Why?
|
| Green Fluorescent Proteins | 6 | 2019 | 2063 | 0.220 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4309 | 0.210 |
Why?
|
| Diffusion of Innovation | 2 | 2020 | 729 | 0.210 |
Why?
|
| Phenyl Ethers | 2 | 2002 | 62 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 2690 | 0.210 |
Why?
|
| Molecular Sequence Data | 8 | 2016 | 17630 | 0.210 |
Why?
|
| Cell Physiological Phenomena | 1 | 2004 | 149 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8542 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 6 | 2016 | 3793 | 0.210 |
Why?
|
| Rejuvenation | 2 | 2014 | 105 | 0.210 |
Why?
|
| Sequence Alignment | 3 | 2017 | 2178 | 0.210 |
Why?
|
| Fluorobenzenes | 1 | 2004 | 179 | 0.210 |
Why?
|
| Models, Biological | 7 | 2021 | 9461 | 0.210 |
Why?
|
| Protein Binding | 11 | 2017 | 9345 | 0.210 |
Why?
|
| Drug Carriers | 1 | 2007 | 706 | 0.210 |
Why?
|
| Homeostasis | 4 | 2017 | 3321 | 0.210 |
Why?
|
| Mass Spectrometry | 3 | 2017 | 2189 | 0.210 |
Why?
|
| Cholesterol, Dietary | 2 | 2001 | 224 | 0.210 |
Why?
|
| Heparin | 5 | 2014 | 1632 | 0.200 |
Why?
|
| Hyperglycemia | 3 | 2007 | 1375 | 0.200 |
Why?
|
| Gluconeogenesis | 1 | 2023 | 185 | 0.200 |
Why?
|
| Neoplasm Proteins | 3 | 2003 | 3607 | 0.200 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 3 | 2009 | 225 | 0.200 |
Why?
|
| Female | 51 | 2024 | 392203 | 0.200 |
Why?
|
| Phosphorylation | 5 | 2020 | 8311 | 0.200 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2003 | 241 | 0.190 |
Why?
|
| Blood Pressure | 8 | 2013 | 8473 | 0.190 |
Why?
|
| Carotid Artery Diseases | 3 | 2004 | 877 | 0.190 |
Why?
|
| Proteoglycans | 2 | 2005 | 803 | 0.190 |
Why?
|
| Diastole | 2 | 2014 | 781 | 0.190 |
Why?
|
| MicroRNAs | 3 | 2018 | 3802 | 0.190 |
Why?
|
| Lipid Metabolism | 3 | 2012 | 1896 | 0.190 |
Why?
|
| Imidazoles | 3 | 2019 | 1175 | 0.190 |
Why?
|
| Chemotaxis | 3 | 2015 | 598 | 0.190 |
Why?
|
| Receptors, Lipoprotein | 1 | 2001 | 88 | 0.190 |
Why?
|
| Mast Cells | 3 | 2019 | 1392 | 0.190 |
Why?
|
| CD40 Ligand | 1 | 2003 | 521 | 0.180 |
Why?
|
| Nitric Oxide | 2 | 2007 | 2135 | 0.180 |
Why?
|
| Vasculitis | 2 | 2005 | 522 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 2 | 2008 | 2644 | 0.180 |
Why?
|
| Coronary Thrombosis | 1 | 2003 | 440 | 0.180 |
Why?
|
| Coronary Restenosis | 1 | 2003 | 396 | 0.180 |
Why?
|
| Pressure | 5 | 2010 | 1150 | 0.180 |
Why?
|
| Nitric Oxide Synthase | 3 | 2004 | 908 | 0.180 |
Why?
|
| Polyploidy | 2 | 2012 | 119 | 0.180 |
Why?
|
| Interleukin-13 | 3 | 2022 | 392 | 0.180 |
Why?
|
| Pesticides | 1 | 2023 | 296 | 0.180 |
Why?
|
| Ventricular Function, Left | 6 | 2019 | 3873 | 0.180 |
Why?
|
| Receptors, LDL | 2 | 2018 | 488 | 0.170 |
Why?
|
| Dipeptidyl Peptidase 4 | 3 | 2011 | 91 | 0.170 |
Why?
|
| Genes, Reporter | 5 | 2019 | 1525 | 0.170 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2014 | 3621 | 0.170 |
Why?
|
| Random Allocation | 4 | 2013 | 2392 | 0.170 |
Why?
|
| Blood Glucose | 4 | 2014 | 6390 | 0.170 |
Why?
|
| Toluene | 1 | 2019 | 32 | 0.170 |
Why?
|
| Dimerization | 2 | 2016 | 890 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 4 | 2023 | 1962 | 0.170 |
Why?
|
| Ligation | 4 | 2005 | 446 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2014 | 3730 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 1169 | 0.170 |
Why?
|
| Enzyme Inhibitors | 5 | 2009 | 3705 | 0.170 |
Why?
|
| Blood Flow Velocity | 5 | 2005 | 1369 | 0.170 |
Why?
|
| Receptor, Angiotensin, Type 1 | 4 | 2002 | 153 | 0.170 |
Why?
|
| Blotting, Western | 7 | 2005 | 5034 | 0.170 |
Why?
|
| Microtubules | 2 | 2018 | 1073 | 0.170 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 905 | 0.170 |
Why?
|
| Single-Blind Method | 3 | 2013 | 1575 | 0.170 |
Why?
|
| Tenascin | 1 | 1999 | 61 | 0.160 |
Why?
|
| Transfection | 6 | 2006 | 5765 | 0.160 |
Why?
|
| Recovery of Function | 3 | 2020 | 2977 | 0.160 |
Why?
|
| Models, Molecular | 5 | 2017 | 5433 | 0.160 |
Why?
|
| Ileum | 1 | 2021 | 557 | 0.160 |
Why?
|
| Structure-Activity Relationship | 3 | 2017 | 3074 | 0.160 |
Why?
|
| Forecasting | 2 | 2020 | 2924 | 0.160 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 289 | 0.160 |
Why?
|
| Enzyme Activation | 3 | 2020 | 3591 | 0.160 |
Why?
|
| Ubiquitin | 2 | 2019 | 839 | 0.160 |
Why?
|
| Antioxidants | 3 | 2004 | 1669 | 0.160 |
Why?
|
| I-kappa B Proteins | 1 | 1999 | 211 | 0.160 |
Why?
|
| Embryonic Stem Cells | 3 | 2013 | 1262 | 0.160 |
Why?
|
| Matrix Metalloproteinase 1 | 5 | 2003 | 145 | 0.160 |
Why?
|
| Benzothiazoles | 1 | 2019 | 247 | 0.160 |
Why?
|
| Follistatin | 2 | 2017 | 137 | 0.160 |
Why?
|
| 3T3-L1 Cells | 2 | 2011 | 209 | 0.160 |
Why?
|
| Saphenous Vein | 3 | 1998 | 516 | 0.160 |
Why?
|
| Indoles | 2 | 2015 | 1830 | 0.160 |
Why?
|
| 3T3 Cells | 3 | 2010 | 1085 | 0.150 |
Why?
|
| Finite Element Analysis | 3 | 2004 | 437 | 0.150 |
Why?
|
| Genetic Engineering | 2 | 2021 | 931 | 0.150 |
Why?
|
| Injections | 3 | 2006 | 832 | 0.150 |
Why?
|
| Cell Lineage | 1 | 2007 | 2553 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2021 | 4058 | 0.150 |
Why?
|
| Gene Transfer Techniques | 3 | 2012 | 1202 | 0.150 |
Why?
|
| Scleroderma, Systemic | 1 | 2022 | 344 | 0.150 |
Why?
|
| Muscle Cells | 2 | 2011 | 195 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5838 | 0.150 |
Why?
|
| Muscle Proteins | 2 | 2005 | 1152 | 0.150 |
Why?
|
| STAT Transcription Factors | 1 | 2018 | 188 | 0.150 |
Why?
|
| Inflammasomes | 1 | 2023 | 526 | 0.150 |
Why?
|
| Cattle | 6 | 2016 | 3841 | 0.150 |
Why?
|
| Ambystoma mexicanum | 1 | 2018 | 51 | 0.140 |
Why?
|
| Acetylation | 1 | 2020 | 1055 | 0.140 |
Why?
|
| Receptors, Chemokine | 1 | 2000 | 652 | 0.140 |
Why?
|
| Janus Kinases | 1 | 2018 | 248 | 0.140 |
Why?
|
| Angiotensin II | 4 | 2009 | 849 | 0.140 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2019 | 111 | 0.140 |
Why?
|
| Coronary Disease | 4 | 2005 | 5911 | 0.140 |
Why?
|
| Laminin | 3 | 2005 | 408 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 234 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2019 | 299 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 2 | 2006 | 1582 | 0.140 |
Why?
|
| Giant Cells | 1 | 2017 | 188 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2009 | 1135 | 0.140 |
Why?
|
| Tensile Strength | 2 | 1994 | 330 | 0.140 |
Why?
|
| Nanostructures | 3 | 2017 | 551 | 0.140 |
Why?
|
| Hypoglycemic Agents | 3 | 2020 | 3085 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2022 | 3077 | 0.140 |
Why?
|
| Cell Size | 4 | 2004 | 624 | 0.140 |
Why?
|
| Sialoglycoproteins | 1 | 1997 | 315 | 0.140 |
Why?
|
| Amino Acids | 1 | 2023 | 1718 | 0.140 |
Why?
|
| Electrocardiography | 4 | 2011 | 6346 | 0.140 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 1998 | 352 | 0.140 |
Why?
|
| Wound Healing | 3 | 2008 | 2802 | 0.140 |
Why?
|
| Chondroitin Sulfates | 2 | 2010 | 174 | 0.130 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2003 | 1723 | 0.130 |
Why?
|
| Carbohydrate Metabolism | 1 | 2017 | 262 | 0.130 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 2 | 2009 | 267 | 0.130 |
Why?
|
| Chimera | 1 | 2017 | 453 | 0.130 |
Why?
|
| NAD | 1 | 2020 | 614 | 0.130 |
Why?
|
| Cell Adhesion | 5 | 2005 | 3088 | 0.130 |
Why?
|
| Coronary Vessels | 5 | 2009 | 3095 | 0.130 |
Why?
|
| Cell Membrane | 3 | 2020 | 3680 | 0.130 |
Why?
|
| Mice, Transgenic | 9 | 2012 | 9526 | 0.130 |
Why?
|
| Follistatin-Related Proteins | 1 | 2016 | 48 | 0.130 |
Why?
|
| Stem Cell Research | 1 | 2016 | 37 | 0.130 |
Why?
|
| Carotid Arteries | 3 | 2007 | 941 | 0.130 |
Why?
|
| Pyrimidines | 2 | 2005 | 3027 | 0.130 |
Why?
|
| Receptor, Angiotensin, Type 2 | 3 | 2001 | 60 | 0.130 |
Why?
|
| Nuclear Envelope | 2 | 2007 | 162 | 0.130 |
Why?
|
| Adrenergic Agents | 1 | 2016 | 74 | 0.130 |
Why?
|
| Lysine | 1 | 2020 | 993 | 0.130 |
Why?
|
| Vagotomy | 1 | 2015 | 83 | 0.130 |
Why?
|
| Connective Tissue Cells | 1 | 2015 | 49 | 0.130 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 392 | 0.130 |
Why?
|
| Muscles | 2 | 2021 | 1573 | 0.130 |
Why?
|
| Protease Inhibitors | 1 | 1999 | 753 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2019 | 497 | 0.120 |
Why?
|
| Adenosine Triphosphate | 2 | 2012 | 1988 | 0.120 |
Why?
|
| Tissue Scaffolds | 3 | 2017 | 932 | 0.120 |
Why?
|
| Transcription Factors | 7 | 2016 | 12116 | 0.120 |
Why?
|
| Cell Culture Techniques | 3 | 2015 | 1662 | 0.120 |
Why?
|
| Species Specificity | 1 | 2019 | 2410 | 0.120 |
Why?
|
| Acetylcysteine | 3 | 2002 | 260 | 0.120 |
Why?
|
| Cartilage, Articular | 2 | 2014 | 1099 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 2409 | 0.120 |
Why?
|
| Protein Conformation | 3 | 2016 | 3965 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2001 | 1409 | 0.120 |
Why?
|
| Cytokines | 5 | 2022 | 7373 | 0.120 |
Why?
|
| Cell Division | 3 | 2012 | 4457 | 0.120 |
Why?
|
| Culture Media, Serum-Free | 1 | 2014 | 148 | 0.120 |
Why?
|
| Horses | 1 | 2015 | 300 | 0.120 |
Why?
|
| Organ Specificity | 3 | 2016 | 1964 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2004 | 1977 | 0.120 |
Why?
|
| Mutation | 11 | 2019 | 30015 | 0.120 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2014 | 28 | 0.120 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2001 | 817 | 0.120 |
Why?
|
| Membrane Glycoproteins | 3 | 2002 | 3688 | 0.120 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2014 | 57 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1608 | 0.120 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 3419 | 0.120 |
Why?
|
| Nanotechnology | 3 | 2017 | 713 | 0.120 |
Why?
|
| STAT6 Transcription Factor | 1 | 2014 | 194 | 0.120 |
Why?
|
| Denervation | 1 | 2015 | 265 | 0.120 |
Why?
|
| Isotope Labeling | 2 | 2012 | 392 | 0.120 |
Why?
|
| Calcinosis | 2 | 2001 | 1469 | 0.120 |
Why?
|
| Amino Acid Substitution | 3 | 2013 | 1739 | 0.120 |
Why?
|
| Calcium Phosphates | 1 | 2015 | 171 | 0.110 |
Why?
|
| Nerve Growth Factor | 1 | 2015 | 158 | 0.110 |
Why?
|
| Disease Progression | 5 | 2019 | 13495 | 0.110 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 122 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1320 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1085 | 0.110 |
Why?
|
| Aortic Diseases | 2 | 2004 | 735 | 0.110 |
Why?
|
| Cytoplasm | 3 | 2012 | 1503 | 0.110 |
Why?
|
| Sheep | 2 | 2015 | 1436 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2006 | 750 | 0.110 |
Why?
|
| Age Factors | 3 | 2019 | 18381 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 393 | 0.110 |
Why?
|
| Keratinocytes | 1 | 1997 | 790 | 0.110 |
Why?
|
| Genetic Vectors | 4 | 2004 | 3392 | 0.110 |
Why?
|
| Cardiotoxins | 1 | 2013 | 36 | 0.110 |
Why?
|
| Snakes | 1 | 2013 | 27 | 0.110 |
Why?
|
| Amphibians | 1 | 2013 | 29 | 0.110 |
Why?
|
| Pulmonary Embolism | 3 | 1996 | 2568 | 0.110 |
Why?
|
| Colon | 1 | 2021 | 1791 | 0.110 |
Why?
|
| Plasmids | 2 | 2009 | 2265 | 0.110 |
Why?
|
| Time Factors | 16 | 2015 | 39908 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2021 | 4269 | 0.110 |
Why?
|
| Norepinephrine | 1 | 2016 | 898 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2019 | 1892 | 0.110 |
Why?
|
| Gene Expression Profiling | 6 | 2018 | 9417 | 0.110 |
Why?
|
| Aortic Valve | 4 | 1998 | 1955 | 0.100 |
Why?
|
| Angina Pectoris | 1 | 1997 | 959 | 0.100 |
Why?
|
| Macaca mulatta | 1 | 2019 | 2328 | 0.100 |
Why?
|
| Hemodynamics | 8 | 2011 | 4160 | 0.100 |
Why?
|
| Cell Respiration | 1 | 2013 | 201 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2019 | 3606 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 1614 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2011 | 10754 | 0.100 |
Why?
|
| RNA | 3 | 2018 | 2713 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 630 | 0.100 |
Why?
|
| Aged | 24 | 2024 | 169092 | 0.100 |
Why?
|
| Proteomics | 3 | 2018 | 3836 | 0.100 |
Why?
|
| Jurkat Cells | 2 | 2011 | 740 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 2015 | 552 | 0.100 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 836 | 0.100 |
Why?
|
| Glucose Clamp Technique | 2 | 2010 | 262 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2003 | 2722 | 0.100 |
Why?
|
| Islets of Langerhans | 1 | 2018 | 1340 | 0.100 |
Why?
|
| Obesity | 2 | 2011 | 12934 | 0.100 |
Why?
|
| NIH 3T3 Cells | 2 | 2012 | 669 | 0.100 |
Why?
|
| Cell Communication | 2 | 2010 | 1654 | 0.100 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 234 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2013 | 172 | 0.100 |
Why?
|
| Anaerobiosis | 1 | 2011 | 139 | 0.100 |
Why?
|
| Immunohistochemistry | 8 | 2010 | 11069 | 0.100 |
Why?
|
| Ligands | 5 | 2019 | 3268 | 0.100 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 3031 | 0.100 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2010 | 133 | 0.100 |
Why?
|
| Constriction, Pathologic | 3 | 2004 | 1096 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2004 | 517 | 0.100 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6927 | 0.100 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 731 | 0.100 |
Why?
|
| Nuclear Pore | 1 | 2012 | 62 | 0.100 |
Why?
|
| Iceland | 1 | 2011 | 184 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 181 | 0.090 |
Why?
|
| Fibronectins | 3 | 2000 | 723 | 0.090 |
Why?
|
| Electric Capacitance | 1 | 2010 | 14 | 0.090 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 726 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2019 | 2604 | 0.090 |
Why?
|
| Guided Tissue Regeneration | 1 | 2011 | 88 | 0.090 |
Why?
|
| Middle Aged | 29 | 2024 | 220603 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 802 | 0.090 |
Why?
|
| Piperazines | 2 | 2019 | 2521 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16968 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 962 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2003 | 1310 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 1 | 2012 | 509 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3599 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 1996 | 628 | 0.090 |
Why?
|
| Halogenated Diphenyl Ethers | 2 | 2002 | 82 | 0.090 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 1557 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 871 | 0.090 |
Why?
|
| Embryoid Bodies | 1 | 2010 | 65 | 0.090 |
Why?
|
| Microspheres | 1 | 2013 | 782 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2004 | 1759 | 0.090 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2002 | 1040 | 0.090 |
Why?
|
| Dependovirus | 3 | 2018 | 712 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2001 | 3205 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2570 | 0.090 |
Why?
|
| Electric Impedance | 2 | 2010 | 751 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 1186 | 0.090 |
Why?
|
| Colitis | 1 | 2019 | 1234 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2049 | 0.090 |
Why?
|
| Receptor, erbB-3 | 1 | 2011 | 143 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 386 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2015 | 982 | 0.090 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2003 | 138 | 0.090 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2011 | 346 | 0.090 |
Why?
|
| Angiogenic Proteins | 1 | 2010 | 101 | 0.090 |
Why?
|
| Cell Transdifferentiation | 1 | 2011 | 186 | 0.090 |
Why?
|
| Crystallization | 2 | 2014 | 533 | 0.090 |
Why?
|
| Adult | 15 | 2024 | 220995 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 5 | 2013 | 5780 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2009 | 3356 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2013 | 0.080 |
Why?
|
| Intercellular Junctions | 1 | 2010 | 195 | 0.080 |
Why?
|
| Microtomy | 1 | 2009 | 44 | 0.080 |
Why?
|
| Rupture, Spontaneous | 2 | 2003 | 362 | 0.080 |
Why?
|
| Alleles | 2 | 2019 | 6861 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2014 | 734 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2004 | 3245 | 0.080 |
Why?
|
| Radiometric Dating | 1 | 2009 | 10 | 0.080 |
Why?
|
| Gels | 2 | 2005 | 420 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 3606 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 1066 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 344 | 0.080 |
Why?
|
| Cell Nucleus Division | 1 | 2009 | 12 | 0.080 |
Why?
|
| Membranes | 2 | 2007 | 165 | 0.080 |
Why?
|
| Protein Stability | 1 | 2011 | 578 | 0.080 |
Why?
|
| Immunity | 1 | 2015 | 994 | 0.080 |
Why?
|
| Chondrocytes | 1 | 2014 | 792 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2014 | 1006 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2013 | 10203 | 0.080 |
Why?
|
| Nuclear Weapons | 1 | 2009 | 12 | 0.080 |
Why?
|
| Desmin | 1 | 2009 | 99 | 0.080 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2009 | 141 | 0.080 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 1169 | 0.080 |
Why?
|
| Tryptases | 1 | 2010 | 176 | 0.080 |
Why?
|
| Receptors, Notch | 1 | 2014 | 743 | 0.080 |
Why?
|
| Kidney | 1 | 2004 | 7044 | 0.080 |
Why?
|
| Progeria | 2 | 2008 | 188 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2023 | 2878 | 0.080 |
Why?
|
| Linkage Disequilibrium | 2 | 2011 | 1994 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2000 | 151 | 0.080 |
Why?
|
| Smoking | 1 | 2005 | 9054 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2003 | 1128 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1745 | 0.080 |
Why?
|
| Benzofurans | 1 | 2009 | 139 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2019 | 3394 | 0.080 |
Why?
|
| Hindlimb | 1 | 2011 | 513 | 0.080 |
Why?
|
| Arterioles | 2 | 2011 | 250 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 927 | 0.080 |
Why?
|
| Phenotype | 4 | 2020 | 16572 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1994 | 1163 | 0.080 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 665 | 0.080 |
Why?
|
| Proteome | 1 | 2018 | 1857 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1602 | 0.080 |
Why?
|
| Chromatin | 1 | 2020 | 2955 | 0.080 |
Why?
|
| Biotin | 1 | 2009 | 252 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2013 | 1133 | 0.080 |
Why?
|
| Farnesyltranstransferase | 1 | 2008 | 71 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2024 | 2048 | 0.080 |
Why?
|
| Adenoviridae | 2 | 2002 | 1084 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 1132 | 0.070 |
Why?
|
| Regional Blood Flow | 2 | 2006 | 1496 | 0.070 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 532 | 0.070 |
Why?
|
| Telomere | 1 | 2014 | 942 | 0.070 |
Why?
|
| Ultrasonography | 8 | 2006 | 5965 | 0.070 |
Why?
|
| Myosins | 2 | 2003 | 404 | 0.070 |
Why?
|
| Microscopy, Video | 2 | 2007 | 241 | 0.070 |
Why?
|
| Physical Stimulation | 3 | 2004 | 517 | 0.070 |
Why?
|
| Predictive Value of Tests | 7 | 2003 | 15250 | 0.070 |
Why?
|
| Ketosis | 1 | 2007 | 46 | 0.070 |
Why?
|
| Carbon Radioisotopes | 1 | 2009 | 561 | 0.070 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2007 | 72 | 0.070 |
Why?
|
| DNA Replication | 1 | 2014 | 1414 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2014 | 862 | 0.070 |
Why?
|
| Glycolysis | 1 | 2011 | 835 | 0.070 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 380 | 0.070 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2007 | 94 | 0.070 |
Why?
|
| Body Composition | 1 | 2017 | 2426 | 0.070 |
Why?
|
| Genomics | 1 | 2003 | 5822 | 0.070 |
Why?
|
| Materials Testing | 2 | 2014 | 863 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 1994 | 1269 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 727 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2019 | 2118 | 0.070 |
Why?
|
| Autophagy | 1 | 2015 | 1327 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2009 | 1228 | 0.070 |
Why?
|
| Hyperinsulinism | 1 | 2010 | 400 | 0.070 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2006 | 56 | 0.070 |
Why?
|
| Cholesterol | 3 | 2005 | 2902 | 0.070 |
Why?
|
| Analysis of Variance | 4 | 2009 | 6223 | 0.070 |
Why?
|
| Models, Animal | 2 | 2010 | 2108 | 0.070 |
Why?
|
| Image Cytometry | 1 | 2007 | 54 | 0.070 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 887 | 0.070 |
Why?
|
| Survival Analysis | 5 | 2008 | 10072 | 0.070 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2006 | 52 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2010 | 1150 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2004 | 36401 | 0.070 |
Why?
|
| Antigens, CD | 3 | 2003 | 3998 | 0.070 |
Why?
|
| Rabbits | 3 | 2005 | 4770 | 0.070 |
Why?
|
| Systole | 2 | 1999 | 935 | 0.070 |
Why?
|
| Muscular Dystrophies | 1 | 2009 | 390 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 682 | 0.070 |
Why?
|
| Osteoarthritis | 1 | 2014 | 1063 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2001 | 829 | 0.070 |
Why?
|
| Treatment Outcome | 9 | 2017 | 64572 | 0.070 |
Why?
|
| Palliative Care | 1 | 2021 | 3593 | 0.070 |
Why?
|
| Nuclear Lamina | 1 | 2006 | 46 | 0.070 |
Why?
|
| RNA Interference | 1 | 2014 | 2829 | 0.070 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 768 | 0.060 |
Why?
|
| Sensitivity and Specificity | 9 | 2013 | 14649 | 0.060 |
Why?
|
| Protein Precursors | 2 | 2010 | 1131 | 0.060 |
Why?
|
| Biotinylation | 1 | 2006 | 184 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2003 | 3776 | 0.060 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2005 | 21 | 0.060 |
Why?
|
| Protein Kinase C | 2 | 2002 | 1202 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2003 | 12043 | 0.060 |
Why?
|
| Pericytes | 1 | 2008 | 294 | 0.060 |
Why?
|
| Heparitin Sulfate | 2 | 2010 | 223 | 0.060 |
Why?
|
| Methionine | 1 | 2008 | 572 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2013 | 699 | 0.060 |
Why?
|
| Comorbidity | 3 | 2019 | 10507 | 0.060 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2005 | 122 | 0.060 |
Why?
|
| Biodegradation, Environmental | 1 | 2005 | 216 | 0.060 |
Why?
|
| Coronary Artery Bypass | 2 | 2010 | 2188 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2010 | 1336 | 0.060 |
Why?
|
| Chemokine CCL11 | 2 | 2004 | 128 | 0.060 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 222 | 0.060 |
Why?
|
| Dystroglycans | 1 | 2004 | 62 | 0.060 |
Why?
|
| Free Radical Scavengers | 2 | 2009 | 211 | 0.060 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2005 | 144 | 0.060 |
Why?
|
| Hydrogels | 2 | 2014 | 720 | 0.060 |
Why?
|
| Oxidants | 1 | 2005 | 169 | 0.060 |
Why?
|
| Troponin I | 1 | 2009 | 650 | 0.060 |
Why?
|
| Adolescent | 5 | 2019 | 88247 | 0.060 |
Why?
|
| Interferon-gamma | 3 | 2004 | 3145 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2003 | 613 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 624 | 0.060 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2004 | 131 | 0.060 |
Why?
|
| Computer Simulation | 4 | 2013 | 6233 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 271 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2005 | 1989 | 0.060 |
Why?
|
| Focal Adhesions | 1 | 2004 | 115 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2004 | 291 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2012 | 1350 | 0.060 |
Why?
|
| Membrane Fluidity | 1 | 2003 | 68 | 0.060 |
Why?
|
| Neoplasms | 2 | 2024 | 22131 | 0.060 |
Why?
|
| Sex Factors | 2 | 2011 | 10549 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 2726 | 0.060 |
Why?
|
| Cell Cycle Proteins | 2 | 2006 | 3447 | 0.060 |
Why?
|
| Reproducibility of Results | 7 | 2009 | 20077 | 0.060 |
Why?
|
| Integrin alpha6beta1 | 1 | 2003 | 19 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2004 | 169 | 0.060 |
Why?
|
| Phenylephrine | 1 | 2004 | 293 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2004 | 277 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2005 | 278 | 0.050 |
Why?
|
| Solubility | 2 | 2003 | 1089 | 0.050 |
Why?
|
| Exercise | 1 | 2020 | 5886 | 0.050 |
Why?
|
| Clinical Trials as Topic | 3 | 2016 | 7995 | 0.050 |
Why?
|
| Nuclease Protection Assays | 1 | 2002 | 14 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2003 | 96 | 0.050 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2024 | 296 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2002 | 108 | 0.050 |
Why?
|
| Nuclear Proteins | 3 | 2008 | 5789 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2006 | 1162 | 0.050 |
Why?
|
| Amlodipine | 1 | 2003 | 84 | 0.050 |
Why?
|
| Pyridines | 2 | 2006 | 2875 | 0.050 |
Why?
|
| Heart Conduction System | 2 | 2005 | 992 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2007 | 770 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2004 | 5863 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2005 | 334 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2003 | 226 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2004 | 445 | 0.050 |
Why?
|
| Aorta, Thoracic | 2 | 2000 | 1096 | 0.050 |
Why?
|
| Heterozygote | 2 | 2006 | 2780 | 0.050 |
Why?
|
| Electricity | 1 | 2023 | 175 | 0.050 |
Why?
|
| Ischemia | 1 | 2011 | 1885 | 0.050 |
Why?
|
| Double-Blind Method | 4 | 2005 | 12333 | 0.050 |
Why?
|
| Gene Expression | 3 | 2013 | 7569 | 0.050 |
Why?
|
| Rodentia | 1 | 2023 | 261 | 0.050 |
Why?
|
| Actinin | 1 | 2003 | 163 | 0.050 |
Why?
|
| Survival Rate | 5 | 2004 | 12719 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2011 | 2624 | 0.050 |
Why?
|
| Nerve Fibers | 1 | 2005 | 707 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 350 | 0.050 |
Why?
|
| Prognosis | 9 | 2011 | 29601 | 0.050 |
Why?
|
| Young Adult | 2 | 2019 | 59191 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2639 | 0.050 |
Why?
|
| Enoxaparin | 1 | 2004 | 391 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 705 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2009 | 834 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2004 | 593 | 0.050 |
Why?
|
| Chromatography, Agarose | 1 | 2001 | 29 | 0.050 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2001 | 85 | 0.050 |
Why?
|
| Biglycan | 1 | 2001 | 10 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2007 | 1594 | 0.050 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2001 | 52 | 0.050 |
Why?
|
| Cysteine | 1 | 2006 | 891 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2024 | 422 | 0.050 |
Why?
|
| Versicans | 1 | 2001 | 40 | 0.050 |
Why?
|
| Fasting | 1 | 2007 | 1603 | 0.050 |
Why?
|
| Injections, Intra-Articular | 2 | 2014 | 280 | 0.050 |
Why?
|
| Cardiac Volume | 1 | 2002 | 196 | 0.050 |
Why?
|
| Decorin | 1 | 2001 | 38 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 901 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2002 | 433 | 0.050 |
Why?
|
| Receptors, Scavenger | 1 | 2001 | 123 | 0.050 |
Why?
|
| Receptors, CCR3 | 1 | 2000 | 62 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 494 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 2817 | 0.050 |
Why?
|
| Bioprosthesis | 1 | 2005 | 591 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 3798 | 0.050 |
Why?
|
| Vitamins | 1 | 2009 | 1635 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 29869 | 0.050 |
Why?
|
| Ramipril | 2 | 2001 | 102 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2005 | 691 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2019 | 4117 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2001 | 141 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2002 | 560 | 0.040 |
Why?
|
| Equipment Design | 3 | 2015 | 3501 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2005 | 4340 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2002 | 527 | 0.040 |
Why?
|
| RNA Stability | 1 | 2002 | 320 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 1748 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 36157 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6403 | 0.040 |
Why?
|
| Necrosis | 1 | 2004 | 1610 | 0.040 |
Why?
|
| 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1 | 1999 | 5 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 982 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 2000 | 102 | 0.040 |
Why?
|
| Image Enhancement | 2 | 2009 | 2881 | 0.040 |
Why?
|
| Osteonectin | 1 | 1999 | 33 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 4569 | 0.040 |
Why?
|
| Lung | 3 | 2006 | 9999 | 0.040 |
Why?
|
| Peripheral Arterial Disease | 1 | 2011 | 1271 | 0.040 |
Why?
|
| Skin | 3 | 2022 | 4472 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2003 | 774 | 0.040 |
Why?
|
| Losartan | 1 | 2001 | 263 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 694 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 795 | 0.040 |
Why?
|
| Larva | 1 | 2021 | 509 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2024 | 899 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2006 | 1697 | 0.040 |
Why?
|
| Serum Amyloid A Protein | 1 | 1999 | 126 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 283 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 39062 | 0.040 |
Why?
|
| Binding Sites | 1 | 2008 | 6051 | 0.040 |
Why?
|
| Homozygote | 2 | 2019 | 1776 | 0.040 |
Why?
|
| Catalase | 1 | 1999 | 218 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2004 | 1056 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2004 | 1112 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17878 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2011 | 2190 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2002 | 730 | 0.040 |
Why?
|
| Papillary Muscles | 1 | 1999 | 192 | 0.040 |
Why?
|
| Child | 4 | 2019 | 80089 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 1971 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1738 | 0.040 |
Why?
|
| Brain | 2 | 2016 | 27100 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2001 | 1262 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 1999 | 249 | 0.040 |
Why?
|
| Receptors, Angiotensin | 1 | 1998 | 141 | 0.040 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 1998 | 63 | 0.040 |
Why?
|
| Growth Differentiation Factor 2 | 1 | 2018 | 27 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1998 | 343 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1754 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2004 | 8998 | 0.040 |
Why?
|
| Scattering, Small Angle | 1 | 2018 | 63 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2011 | 41464 | 0.040 |
Why?
|
| Perception | 1 | 2024 | 1199 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 1117 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 1927 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 642 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 482 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2004 | 1503 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2001 | 584 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2002 | 2202 | 0.040 |
Why?
|
| Indazoles | 1 | 1999 | 304 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 3415 | 0.040 |
Why?
|
| DNA-Binding Proteins | 4 | 2007 | 9586 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1242 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2001 | 483 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3492 | 0.040 |
Why?
|
| Structural Homology, Protein | 1 | 2017 | 87 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1998 | 315 | 0.030 |
Why?
|
| Prospective Studies | 8 | 2013 | 54364 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 1997 | 144 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1404 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 858 | 0.030 |
Why?
|
| Chronic Disease | 4 | 2019 | 9310 | 0.030 |
Why?
|
| Biological Transport | 1 | 2021 | 2089 | 0.030 |
Why?
|
| Base Sequence | 2 | 2005 | 12420 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2017 | 156 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 2 | 2013 | 319 | 0.030 |
Why?
|
| Activins | 1 | 2018 | 210 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2008 | 4470 | 0.030 |
Why?
|
| Health Status | 2 | 2001 | 4076 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2017 | 531 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1997 | 299 | 0.030 |
Why?
|
| Cyclohexylamines | 1 | 2015 | 21 | 0.030 |
Why?
|
| Homocysteine | 1 | 1999 | 637 | 0.030 |
Why?
|
| Calcium | 2 | 2015 | 5717 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 15908 | 0.030 |
Why?
|
| Gelatinases | 1 | 1995 | 88 | 0.030 |
Why?
|
| Adipocytes | 2 | 2017 | 1187 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3426 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 1999 | 1703 | 0.030 |
Why?
|
| Myoblasts | 1 | 2017 | 231 | 0.030 |
Why?
|
| Neural Tube | 1 | 2015 | 48 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 302 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 2003 | 859 | 0.030 |
Why?
|
| Neuroglia | 1 | 2021 | 954 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1998 | 584 | 0.030 |
Why?
|
| Organoids | 1 | 2021 | 744 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1995 | 186 | 0.030 |
Why?
|
| Luciferases | 1 | 2017 | 712 | 0.030 |
Why?
|
| Observer Variation | 2 | 1999 | 2607 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1848 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2004 | 2055 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2016 | 222 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2002 | 2916 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2019 | 823 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 1376 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2003 | 2637 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 2009 | 826 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 5671 | 0.030 |
Why?
|
| Stainless Steel | 1 | 1994 | 79 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2004 | 2073 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1996 | 522 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1999 | 1088 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1995 | 813 | 0.030 |
Why?
|
| Shear Strength | 2 | 2005 | 160 | 0.030 |
Why?
|
| Trachea | 1 | 2000 | 1089 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1175 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6305 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2021 | 1333 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2018 | 1230 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2011 | 12942 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2001 | 1734 | 0.030 |
Why?
|
| Sarcomeres | 2 | 2009 | 369 | 0.030 |
Why?
|
| Drosophila | 1 | 2021 | 1494 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 1994 | 440 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2004 | 2425 | 0.030 |
Why?
|
| Risk Factors | 6 | 2004 | 74128 | 0.030 |
Why?
|
| Antibodies | 1 | 2001 | 2413 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 1994 | 210 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10175 | 0.030 |
Why?
|
| Kinetics | 1 | 2001 | 6370 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2051 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1994 | 338 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 2495 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 197 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 659 | 0.030 |
Why?
|
| Cardiac Tamponade | 1 | 1994 | 173 | 0.030 |
Why?
|
| Tretinoin | 1 | 2015 | 519 | 0.030 |
Why?
|
| Atrophy | 1 | 2018 | 1632 | 0.030 |
Why?
|
| Diffusion | 1 | 2014 | 814 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1502 | 0.030 |
Why?
|
| Acute Disease | 3 | 2003 | 7236 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1998 | 1185 | 0.030 |
Why?
|
| Italy | 1 | 1994 | 842 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2014 | 1157 | 0.030 |
Why?
|
| Rupture | 1 | 1994 | 443 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 1989 | 0.020 |
Why?
|
| Rotation | 1 | 1994 | 517 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 2746 | 0.020 |
Why?
|
| Mitral Valve Insufficiency | 2 | 1998 | 1400 | 0.020 |
Why?
|
| Isotopes | 1 | 2012 | 125 | 0.020 |
Why?
|
| Reference Values | 1 | 2019 | 4919 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 642 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2001 | 2242 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2012 | 189 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 2019 | 757 | 0.020 |
Why?
|
| Genome | 1 | 2019 | 1737 | 0.020 |
Why?
|
| Vascular Patency | 1 | 1994 | 911 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 1994 | 3410 | 0.020 |
Why?
|
| Thiophenes | 1 | 2015 | 569 | 0.020 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Cell Count | 1 | 2015 | 1834 | 0.020 |
Why?
|
| Lymphopoiesis | 1 | 2012 | 133 | 0.020 |
Why?
|
| Surface Properties | 1 | 1994 | 1162 | 0.020 |
Why?
|
| Polysaccharide-Lyases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Chest Pain | 2 | 1997 | 1091 | 0.020 |
Why?
|
| Nanofibers | 1 | 2011 | 66 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2019 | 42193 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 4512 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2015 | 869 | 0.020 |
Why?
|
| Enterocytes | 1 | 2012 | 220 | 0.020 |
Why?
|
| Acetanilides | 1 | 2011 | 169 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2011 | 269 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6188 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 475 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2004 | 5292 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 1698 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 1994 | 617 | 0.020 |
Why?
|
| ROC Curve | 2 | 1994 | 3575 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 836 | 0.020 |
Why?
|
| Lipids | 1 | 2001 | 3332 | 0.020 |
Why?
|
| Mesoderm | 1 | 2013 | 674 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2015 | 1329 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 2214 | 0.020 |
Why?
|
| Oxypurinol | 1 | 2009 | 8 | 0.020 |
Why?
|
| Informed Consent | 1 | 2016 | 1007 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2021 | 2317 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 1996 | 1048 | 0.020 |
Why?
|
| Tissue Survival | 1 | 2009 | 119 | 0.020 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2009 | 24 | 0.020 |
Why?
|
| Drug Design | 1 | 2014 | 1045 | 0.020 |
Why?
|
| Compliance | 1 | 2009 | 99 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2012 | 558 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 584 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 15829 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 2009 | 69 | 0.020 |
Why?
|
| Canada | 1 | 1994 | 2120 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2009 | 294 | 0.020 |
Why?
|
| Hemorheology | 1 | 2009 | 144 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1994 | 2925 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 14024 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2004 | 4785 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1994 | 1154 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1994 | 786 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 1130 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2003 | 5074 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 295 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 1182 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2009 | 696 | 0.020 |
Why?
|
| Intranuclear Space | 1 | 2007 | 15 | 0.020 |
Why?
|
| Qb-SNARE Proteins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Consensus | 1 | 2017 | 3117 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 1999 | 3820 | 0.020 |
Why?
|
| Elastin | 1 | 2009 | 298 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1994 | 1493 | 0.020 |
Why?
|
| Prevalence | 1 | 2024 | 15702 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 9171 | 0.020 |
Why?
|
| Polymers | 1 | 1994 | 1614 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2007 | 191 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2009 | 419 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 1995 | 1462 | 0.020 |
Why?
|
| Melanoma | 1 | 2004 | 5696 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2006 | 194 | 0.020 |
Why?
|
| Incidence | 1 | 2004 | 21339 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2012 | 1207 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2001 | 15609 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 399 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2005 | 121 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 1756 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 870 | 0.020 |
Why?
|
| Aortic Valve Stenosis | 1 | 1997 | 2003 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 2577 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2008 | 58919 | 0.010 |
Why?
|
| Immune System | 1 | 2010 | 791 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 866 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1997 | 9644 | 0.010 |
Why?
|
| Paxillin | 1 | 2004 | 86 | 0.010 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2005 | 175 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 843 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1333 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2004 | 115 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2734 | 0.010 |
Why?
|
| Compressive Strength | 1 | 2004 | 158 | 0.010 |
Why?
|
| Bisbenzimidazole | 1 | 2003 | 13 | 0.010 |
Why?
|
| Leukocytes | 1 | 2012 | 2024 | 0.010 |
Why?
|
| Constriction | 1 | 2003 | 168 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2012 | 2115 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2004 | 320 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 438 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 12143 | 0.010 |
Why?
|
| Viscosity | 1 | 2003 | 336 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2007 | 575 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 165 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2006 | 412 | 0.010 |
Why?
|
| Mechanoreceptors | 1 | 2004 | 186 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 1712 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1300 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2010 | 2200 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2635 | 0.010 |
Why?
|
| United States | 2 | 2024 | 72292 | 0.010 |
Why?
|
| Logistic Models | 1 | 1997 | 13248 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2003 | 250 | 0.010 |
Why?
|
| Skull | 1 | 2006 | 818 | 0.010 |
Why?
|
| Mitosis | 1 | 2006 | 1187 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2001 | 2234 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2003 | 776 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 562 | 0.010 |
Why?
|
| Calibration | 1 | 2003 | 817 | 0.010 |
Why?
|
| Cicatrix | 1 | 2006 | 785 | 0.010 |
Why?
|
| Integrin alpha3beta1 | 1 | 2000 | 53 | 0.010 |
Why?
|
| Densitometry | 1 | 2000 | 151 | 0.010 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2001 | 188 | 0.010 |
Why?
|
| Motion | 1 | 2003 | 779 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1692 | 0.010 |
Why?
|
| Heart Septum | 1 | 2001 | 299 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13359 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1996 | 4671 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1079 | 0.010 |
Why?
|
| Linear Models | 2 | 2001 | 5866 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5811 | 0.010 |
Why?
|
| Spine | 1 | 2006 | 1112 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2002 | 696 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 2000 | 302 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1336 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 1606 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 2001 | 407 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6074 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2456 | 0.010 |
Why?
|
| Cognition | 1 | 2014 | 6988 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 2224 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1624 | 0.010 |
Why?
|
| Safety | 1 | 2001 | 1149 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 1999 | 575 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 2703 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 1999 | 578 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2011 | 23974 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1998 | 930 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 4802 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2445 | 0.010 |
Why?
|
| Cell Death | 1 | 2000 | 1677 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1994 | 272 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 4172 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4242 | 0.010 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1997 | 352 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5319 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1994 | 957 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4365 | 0.010 |
Why?
|
| Thorax | 1 | 1994 | 555 | 0.010 |
Why?
|
| Heart Rate | 1 | 2001 | 4181 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2001 | 26065 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 2000 | 3672 | 0.000 |
Why?
|
| Dopamine | 1 | 1994 | 1606 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13383 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22153 | 0.000 |
Why?
|
| Recurrence | 1 | 1997 | 8426 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 12448 | 0.000 |
Why?
|
| Boston | 1 | 1994 | 9313 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 1995 | 80583 | 0.000 |
Why?
|